Ketamine Clinics in Washington, DC

Browse 5 ketamine therapy providers in Washington, District of Columbia.

5 Clinics
4 Spravato Certified
Showing 5 clinics in Washington

Capitol Ketamine & Wellness

3301 New Mexico Avenue, N.W., Suite 228
Washington, DC 20016

ASKP Member Ketamine Therapy
☎ (202) 335-2100 Visit Website

Scott Whetsell

2112 F St NW STE 504
Washington, DC 20037

✓ Spravato Certified
☎ (843) 412-2563

Avesta Ketamine And Wellness

1400 16th St NW STE 101
Washington, DC 20036

✓ Spravato Certified
☎ (301) 381-8381 Visit Website

Inspire Behavioral Health

2112 F St NW STE 201
Washington, DC 20037

✓ Spravato Certified
☎ (703) 592-4600

Raczynski, Christopher, T, (Md)

4325 49TH ST NW STE 200
Washington, DC 20016

✓ Spravato Certified
☎ (202) 888-8620
Treatment Types

Ketamine Treatments in Washington

Explore ketamine treatment options available in Washington, District of Columbia.

IV Ketamine Infusion

Off-label psychiatric use. Verify protocols, evidence, risks, and pricing with the provider.

IM Injection

Off-label psychiatric use. Availability and clinical protocols vary by provider.

Spravato (Esketamine)

FDA-approved nasal spray administered in a REMS-certified healthcare setting.

Ketamine-Assisted Psychotherapy

Off-label and still under study. Evidence, training, and protocols vary.

Compare source evidence in Washington, District of Columbia

These 5 directory records are starting points for checking providers. 4 carry an imported Spravato REMS flag and 1 come from ASKP membership data. Neither an NPI entry nor association membership confirms a particular therapy, current intake, price or suitability.

No additional provider-site service check has been recorded for this city cohort. Confirm each listed service directly.

Questions before choosing a service

  • Which exact medicine, formulation and route does this location offer? Distinguish Spravato from other ketamine products.
  • Who evaluates eligibility, and how can you verify that clinician’s state licence?
  • What observation, follow-up and urgent-care arrangements does the provider explain?
  • What does the written total include: evaluation, medicine, monitoring, follow-up and any facility fee? Confirm coverage with your insurer.

FDA maintains compounding risk alerts, including its ketamine alerts. Read the current product information and discuss risks and alternatives with your treating clinician. Directory inclusion is not a treatment recommendation or a guarantee of availability.

Directory sources and limits · Spravato information · Questions and treatment distinctions